Prices are updated after-hours


Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date

tags : Collaboration    crawled date : 2020 - 12 - 01    save search

Predictive Oncology and Dr. Daniel Carter Collaborating to Develop a Potential COVID-19 Vaccine Utilizing Novel Nanoparticle Vaccine Platform, Based on NSP-10
Published: 2020-05-06 (Crawled : 22:17) - globenewswire.com
POAI | $1.34 3.88% 3.73% 24K twitter stocktwits trandingview |
Health Technology
| | O: 30.14% H: 2.63% C: -21.05%

collaboration covid vaccine potential
Dynavax and Mount Sinai Announce Collaboration to Develop a Universal Influenza Vaccine Candidate with CpG 1018 Adjuvant
Published: 2020-07-16 (Crawled : 22:16) - globenewswire.com
DVAX | $11.42 -2.89% -2.98% 1.3M twitter stocktwits trandingview |
Health Technology
| | O: 3.16% H: 1.8% C: -1.72%

collaboration vaccine influenza announces collaboration
Dynavax and Medigen Announce Collaboration to Develop a Novel Adjuvanted COVID-19 Vaccine Candidate
Published: 2020-07-23 (Crawled : 22:16) - globenewswire.com
DVAX | $11.42 -2.89% -2.98% 1.3M twitter stocktwits trandingview |
Health Technology
| | O: 0.99% H: 5.17% C: -1.27%

collaboration covid vaccine announces collaboration covid-19
Myovant Sciences Announces Further Financing Support from Sumitomo Dainippon Pharma and Commercial Collaboration with Sunovion Pharmaceuticals
Published: 2020-08-05 (Crawled : 22:15) - globenewswire.com
MYOV | $26.98 -0.04% 0.0% 0 twitter stocktwits trandingview |
Health Technology
| Email alert Add to watchlist

collaboration commercialization pharma
Zymeworks Announces Expansion of Zanidatamab Pivotal Trial in HER2-Amplified Biliary Tract Cancer in Asia in Collaboration With BeiGene
Published: 2020-12-01 (Crawled : 22:01) - biospace.com/
ZYME | $8.555 -0.06% -0.06% 590K twitter stocktwits trandingview |
Health Technology
| | O: 1.35% H: 4.47% C: 2.44%
BGNE | $144.0 3.61% 3.48% 220K twitter stocktwits trandingview |
Health Technology
| | O: 1.69% H: 0.96% C: -5.2%

collaboration cancer trial expansion her2+ her2- her2
Sosei Heptares and Biohaven Enter Global Collaboration and License Agreement to Advance Novel Small-Molecule CGRP Antagonist Portfolio
Published: 2020-12-01 (Crawled : 21:00) - biospace.com/
BHVN | News 0 d | $38.72 -2.25% -0.28% 970K twitter stocktwits trandingview |
Health Technology
| | O: 0.71% H: 0.0% C: -3.24%

license collaboration
Gainers vs Losers
62% 38%

Top 10 Gainers
CSSE 4 | $0.4323 183.85% 64.77% 220M twitter stocktwits trandingview |
Consumer Services

BOF | $1.99 70.09% 41.21% 110M twitter stocktwits trandingview |

ILAG | $0.51 6.03% 40.62% 1.7M twitter stocktwits trandingview |

LICN | $0.941 68.04% 40.49% 15M twitter stocktwits trandingview |

AMST | $3.31 65.5% 39.58% 70M twitter stocktwits trandingview |
Technology Services

MTC | $3.615 61.38% 38.04% 9.3M twitter stocktwits trandingview |
Technology Services

WIMI | $1.15 58.53% 36.92% 19M twitter stocktwits trandingview |
Technology Services

AIH | $0.45 12.5% 30.92% 320K twitter stocktwits trandingview |
Health Services

MULN | News | $3.78 38.46% 27.78% 13M twitter stocktwits trandingview |
Information

RILY | $29.86 37.48% 27.26% 12M twitter stocktwits trandingview |
Finance


Your saved searches
Save your searches and get alerts when important news are released.